Stroke is a leading cause of death and disability worldwide. The reasons for increased stroke burden in developing countries are inadequately controlled risk factors resulting from poor public awareness and inadequate infrastructure. Computed tomography and MRI are common neuroimaging modalities used to assess stroke with diffusion-weighted MRI, in particular, being the recommended choice for acute stroke imaging. However, access to these imaging modalities is primarily restricted to major cities and high-income groups. In the case of stroke, the time-window of treatment to limit the damage is of a few hours and needs a point-of-care diagnosis. A low-cost MR system typically achieved at the ultra-lowand very-low-field would meet the need for a geographically accessible and portable solution. We review studies focused on accessible stroke imaging and recent developments in MR methodologies, including hardware, to image at low fields. We hypothesize that in the absence of a formal, rapid stroke triaging system, the value of timely on-site delivery of the scanner to the stroke patient can be significant. To this end, we discuss multiple recent hardware and methods developments in the low-field regime. Our review suggests a compelling need to explore further the trade-offs between high signal, contrast, and accessibility at low fields in low-income communities.

The potential of graphene oxide–Fe3O4 nanoparticle (GO-Fe3O4) composite as an image contrast enhancing material in magnetic resonance imaging has been investigated. Proton relaxivity values were obtained in three different homogeneous dispersions of GO-Fe3O4 composites synthesized by precipitating Fe3O4 nanoparticles in three different reaction mixtures containing 0.01 g, 0.1 g, and 0.2 g of graphene oxide. A noticeable difference in proton relaxivity values was observed between the three cases. A comprehensive structural and magnetic characterization revealed discrete differences in the extent of reduction of the graphene oxide and spacing between the graphene oxide sheets in the three composites. The GO-Fe3O4 composite framework that contained graphene oxide with least extent of reduction of the carboxyl groups and largest spacing between the graphene oxide sheets provided the optimum structure for yielding a very high transverse proton relaxivity value. It was found that the GO-Fe3O4 composites possessed good biocompatibility with normal cell lines, whereas they exhibited considerable toxicity towards breast cancer cells.

A series of Gd dopings in zirconia-toughened alumina (ZTA) systems were undertaken to explore the resultant structural, morphological, hydrothermal aging, and mechanical behavior and imaging contrast abilities. The results from the characterization techniques demonstrate the significance of Gd in preserving the structural stability of ZTA systems. ZTA undergoes phase degradation with 10 wt % Gd at 1400 °C, while the 100 wt % Gd yields GdAlO even at 1200 °C. Gd doping at the intermediate level preserves the structural stability of ZTA systems until 1400 °C. Gd occupies the ZrO lattice, and its gradual accumulation induces tetragonal ZrO (t-ZrO) to cubic ZrO (c-ZrO) phase transition. α-AlO crystallizes at 1200 °C and remains unperturbed except for its reaction with the free Gd ions to yield GdAlO. Aging studies and mechanical tests signify the impeccable role of Gd in ZTA systems to resist phase degradation. Further, the imaging contrast ability of ZTA systems due to Gd doping is verified from the in vitro magnetic resonance imaging (MRI) tests.